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he study in the Journal byMeijboom et al. (1) and the accompanying
ditorial by Nissen (2) seem disconnected from each other.
The Meijboom et al. (1) study was a diagnostic performance
tudy that aimed to establish the accuracy of the newly introduced
echnology. This was a well-executed prospective multicenter,
ultivendor study, the results of which indicate high diagnostic
ccuracy of computed tomography coronary angiography (CTCA)
n symptomatic patients with a high prevalence of coronary artery
isease (CAD) that is superior to other methods of noninvasive
ardiac testing. Furthermore, despite the high prevalence of
ignificant CAD, the ability of CTCA to exclude obstructive
oronary stenosis in the Meijboom et al. (1) study approached
00%, which is higher than that reported for all other forms of
oninvasive cardiac testing.
In contrast, the accompanying editorial by Nissen (2) briefly
iscusses the Meijboom et al. (1) study but concentrated much of
ts text to describing the history of invasive coronary angiography,
tress testing, CTCA, and the need for patient-centered outcomes
tudies for CTCA.
There are several important observations that are worthy of note:
. The cart should not be placed before the horse. The first step
for assessment of any new diagnostic technology is the estab-
lishment of its diagnostic accuracy, and this purpose was well
served by the Meijboom et al. (1) study. Indeed, the Meijboom
et al. (1) study now joins 2 other prospective multicenter studies
(ACCURACY [Assessment by Coronary Computed Tomo-
graphic Angiography of Individuals Undergoing Invasive Cor-
onary Angiography] and CORE-64 [Coronary Artery Evalua-
tion Using 64-Row Multidetector Computed Tomography
Angiography]) evaluating the accuracy of CTCA (3,4). There
have been no large-scale, prospective, multicenter studies of
diagnostic accuracy performed for the stress imaging tests that
have become the de facto standard of care.
. “When will we get there?” is a fair question. “Why aren’t we
there?” is not. The introduction of CTCA occurred 3 years ago,
just enough time to definitively establish diagnostic accuracy.
Studies regarding CTCA now need to assess its costs to the
health care system and its clinical effectiveness for patients, and
these types of trials have been proposed and designed and are
being implemented.
. “Res ipsa loquitur.” Until these trials can be completed, com-
mon sense should dictate clinical use of noninvasive cardiac
testing. The majority of patients for whom noninvasive cardiac
testing is most appropriate will not have significant CAD. As
such, a test that can successfully exclude CAD with an accuracy
approaching 100% should be employed to identify individuals
in which no further need for testing or therapy is necessary. cWith its very high negative predictive value, an immediate
benefit of the use of this test would be to eliminate the need for
unnecessary invasive coronary angiography.
. Negative is not necessarily bad. Although it is a complex task to
ascribe an economic value to the intangibles of a negative test in a
scientific study, it is nevertheless very straightforward to a patient.
A “negative test” can be worth as much—if not more—than a
“positive test,” because the value of peace of mind to a concerned
symptomatic patient is unambiguous: it is priceless.
James K. Min, MD
aniel S. Berman, MD
Weill Medical College of Cornell University
ew York Presbyterian Hospital
epartment of Medicine (Cardiology) and Radiology
20 East 70th Street, K415
ew York, New York 10021
-mail: jkm2001@med.cornell.edu
doi:10.1016/j.jacc.2008.12.066
lease note: Dr. Min serves on the Speakers’ Bureau for GE Healthcare and receives
esearch support from GE Healthcare and Vital Images.
EFERENCES
. Meijboom WB, Meijs MF, Schiujf JD, et al. Diagnostic accuracy of
64-slice computed tomography coronary angiography: a prospective,
multicenter, multivendor study. J Am Coll Cardiol 2008;52:2135–44.
. Nissen SE. Limitations of computed tomography coronary angiogra-
phy. J Am Coll Cardiol 2008;52:2145–7.
. Budoff MJ, Dowe D, Jollis JG, et al. Diagnostic performance of
64-multidetector row coronary computed tomographic angiography
for evaluation of coronary artery stenosis in individuals without
known coronary artery disease: results from the prospective multi-
center ACCURACY (Assessment by Coronary Computed Tomo-
graphic Angiography of Individuals Undergoing Invasive Coronary
Angiography) trial. J Am Coll Cardiol 2008;52:1724–32.
. Miller JM, Rochitte CE, Dewey M, et al. Diagnostic performance of
coronary angiography by 64-row CT. N Engl J Med 2008;359:
2324–36.
iagnostic Accuracy of
4-Slice Computed Tomography
oronary Angiography
Flawed Comparison
e read with interest the recent paper by Meijboom et al. (1) and
he corresponding editorial by Nissen (2). We wish to make 3
omments.
First, as with almost all previous validation studies comparingomputed tomography coronary angiography (CTCA) with inva-
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May 12, 2009:1824–7ive coronary angiography (ICA), significant stenoses are defined
s 50% on both quantitative assessment of ICA and visual
stimation of CTCA, with the 2 techniques subsequently com-
ared. The major flaw with this approach is that a measurement of
0% on quantitative coronary angiography is the equivalent of a
isual stenosis of 70%, and therefore there is a systematic overes-
imation of stenosis severity by CTCA contributing to the large
umber of false-positive results. This high false-positive rate is
hen used to highlight the shortcomings of CTCA.
The argument for the use of a 50% stenosis cutoff for CTCA is
ue to the limited spatial resolution of CTCA as discussed in the
issen editorial (2). However, the majority of symptomatic pa-
ients show stenoses well in excess of 70%, and our own previous
ork clearly shows an increase in the positive predictive value of
TCA as compared with single-photon emission computed to-
ography when using a visual cutoff of 70% (3). Furthermore, our
wn validation data demonstrate that this is also true for compar-
son with ICA. In this setting, the associated increase in specificity
ssociated with using a 70% cutoff comes at a cost of significantly
educed sensitivity whilst delivering an identical area under the
urve.
So, although we agree with Nissen’s view (2) that there is no
roven benefit for multimodality noninvasive assessment of coro-
ary artery disease, the targeted use of a combined approach for
atients with apparent lesions of 50% to 69% on CTCA would
llow a more reliable determination of significance in these
ntermediate lesions.
Second, we absolutely share the view that the rapid proliferation
f CTCA and so called “weekend accreditation” is not an appro-
riate strategy for high-quality patient care and therefore would
rgue that both more rigorous accreditation is needed and further
esearch into the most appropriate use of the technology is
aramount.
Third, we would agree that the current research on this
echnology does not support its use beyond the exclusion of
ignificant coronary artery disease. Efforts should now focus on
nswering some of the more fundamental issues limiting the
linical use of CTCA rather than on the exploration of the latest
ew iteration of this seductive technology. We would agree that
urther real-world studies are required. These would include
ssessing the use of a visual 70% stenosis cutoff for defining
ignificant lesions, with the use of a targeted functional testing for
hose with intermediate lesions (50% to 69%). We would also
upport longer-term studies assessing outcome data in patients
valuated with this technology compared with conventional assess-
ent. However, we should not write off CTCA, because there are
ew medical tests that reliably offer a negative predictive value in
xcess of 90%, confirmed again by this study.
Edward D. Nicol, MD, MRCP
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eply
oronary multidetector computed tomography (MDCT) is a
elatively recent noninvasive diagnostic modality. The first 4-slice
omputed tomography (CT) scan was introduced in 1999; since
hen the technique has undergone rapid technological improve-
ents, with introduction of 64-, 128-, 256-, and 320-slice MDCT
canners that have resulted in better, high-quality coronary images.
oronary CT has an enormous appeal, not only because of the
ometimes spectacular and seductive cardiac images—this nonin-
asive diagnostic modality may potentially be able to replace
nvasive coronary angiography. This might have led to initial
ver-enthusiasm that prompted use of this new technique in many
linical situations, although the necessary evidence to support this
as lacking.
However, in the meantime, many CT studies have been
ublished, and together with 3 large-sized multicenter studies it
as been clearly shown that: 1) coronary MDCT is reliable to
ule out the presence of significant coronary stenoses in patients
ith suspected coronary artery disease; and 2) the current
tate-of-the-art CT technique cannot replace invasive coronary
ngiography (1–3). We agree with Drs. Min and Berman that
he ability of CT to exclude disease is important for patients.
ut we also know that coronary CT is not perfect. Several
ssues, including radiation exposure, calcifications, and arrhyth-
ias, are still problematic for coronary CT scanning. Ini-
ially coronary MDCT was associated with a rather high radia-
ion exposure; new protocols (prospective electrocardiogram
ECG]-triggered acquisition) or radiation exposure-reducing
echnology (ECG gated tube modulation) have now achieved
cceptable radiation exposure—as low as 2 to 3 mSv (4).
oronary calcification causing misinterpretation of the presence
nd severity of coronary stenoses remains a significant problem
hat can only be alleviated by better CT detector technology
hat significantly improves the spatial resolution. Very recently
he Gemstone scintillator technology has been introduced that,
n an ideal phantom setting, significantly improved the spatial
esolution up to 230 m. Also the problems of significant
ardiac arrhythmias (atrial fibrillation), which are still problematic
or cardiac CT, will be resolved by new CT technology that needs
nly 1 heartbeat to acquire data for coronary imaging. Another
roblem, raised by Dr. Nicol and colleagues, is overestimation of
isual assessment of the severity of CT coronary stenoses, which has
n the past also been a problem with invasive coronary angiography.
ccurate automated contour-detection algorithms developed for cor-
nary MDCT might resolve this issue. Another important issue
aised by Dr. Nicol and colleagues is the mismatch between CT
natomy imaging and functional imaging. The assumption that a
ignificant stenosis defined as 50% luminal diameter is hemody-
amically significant is not always confirmed by myocardial perfusion
